Chemiesynth (Vapi) Raises Rs 10 Crore via Preference Share Allotment

1,00,00,000 preference shares allotted; Rs 10 crore total capital raised.

Reader Takeaway: The company secures growth capital without diluting equity, but adds a fixed 5% annual dividend obligation.

What just happened

Chemiesynth (Vapi) Limited has completed the private placement of 1 crore Unlisted Non-Convertible Cumulative Redeemable Preference Shares (NCRPS). The company board approved the allotment on October 28, 2026, confirming receipt of full subscription funds. The shares carry a face value of Rs 10 each, totaling a capital infusion of Rs 10 crore.

Key Terms of Issuance

The preference shares carry a 5% annual cumulative dividend rate. The instrument is unsecured and carries a 7-year tenure, maturing on October 28, 2033. Importantly, these shares are not intended for listing on any stock exchange. The terms include both call and put options exercisable by the company and investors, respectively, starting two years from the date of allotment.

Why this matters

This move allows the company to bolster its balance sheet while protecting existing equity shareholders from dilution. By opting for redeemable preference shares rather than common equity, the company retains its capital structure while meeting its immediate funding requirements. However, the 5% cumulative dividend creates a fixed financial commitment that must be serviced, potentially impacting future distributable profits.

What to track next

Shareholders should monitor the company’s capital expenditure or debt repayment plans regarding these new funds. Future annual reports will detail the impact of the cumulative dividend obligation on the company's bottom line.